| Oct 25 |
Wall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know
|
| Oct 24 |
Biotech Stock Roundup: FOLD Settles Patent Dispute, Updates From EDIT & More
|
| Oct 23 |
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?
|
| Oct 23 |
Teva: Great Time To Buy Leading Generic Drugmaker With Growth Indicators And Lower Debt
|
| Oct 22 |
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
|
| Oct 22 |
Teva, Alvotech get expanded FDA approval for Stelara biosimilar
|
| Oct 22 |
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)
|
| Oct 18 |
FOLD Stock Rises on Settling Galafold Patent Dispute With Teva
|
| Oct 18 |
Teva settles patent litigation with Amicus
|
| Oct 18 |
Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?
|
